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Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of approximately 1-2% affecting up to 9% of adults older than 80 years [1] . AF is associated with significant morbidity and mortality [2] . There is a 5-fold increase in the risk of stroke [3] , a decline in quality of life [4] [5] [6] and functional status [7] [8] [9] [10] . The rate of AF-related hospitalizations is projected to rise 2-3 fold in the coming years [11] .
The 2 general approaches to the management of AF involve rate or rhythm control. Rate control focuses on controlling the ventricular response rate with atrioventricular nodal blocking agents and the concurrent use of anticoagulation, if indicated. Rhythm control is aimed at restoring and maintaining sinus rhythm using a plethora of options such as antiarrhythmic drugs and non--pharmacological approaches [12, 13] .
Various studies have attempted to define optimal strategies for the management of AF. The AFFIRM study showed that rhythm control was not superior to rate control in terms of overall mortality, stroke and quality of life [14] . Although these findings were replicated in other studies [15] [16] [17] [18] [19] [20] [21] , guidelines incorporate both approaches, which can be individualized based on variables such as age, symptoms, underlying cardiac abnormalities, medical co-morbidities and the type of AF (paroxysmal, persistent or chronic). The many options offered by these guidelines lead to varying treatment styles, which are based on physician training, experience, patient preference and even misconceptions [12, 13, 22] .
This study explores the management practices for AF between general cardiologists and electrophysiologists in an academic institution. We postulated that there would be greater efforts at rhythm control among the electrophysiologists.
Methods

Study design
Using 2008 as the index year, we attempted to indentify 100 patients with AF who were treated by general cardiologists and 100 patients treated by electrophysiologists in the Northwestern outpatient clinic. Inclusion criteria were age > 40 years old and objective documentation of AF in the medical chart. A total of 236 patients were screened from an electronic data warehouse report. Forty--eight patients were excluded because only atrial flutter was noted or because of lack of objective documentation of AF.
Each chart was reviewed for demographic data and prior history of hypertension, stroke, diabetes mellitus, myocardial infarction, coronary artery disease, congestive heart failure and renal disease. Echocardiogram reports were reviewed for evidence of left atrial enlargement, left ventricular hypertrophy, aortic or mitral valve disease and left ventricular ejection fraction. Valvular disease (aortic insufficiency, aortic regurgitation, mitral stenosis or mitral regurgitation) was considered significant if it was reported to be moderate or severe on echocardiogram reports. Renal disease was considered present if the recorded glomerular filtration rate was < 60 mL/min.
The type of AF was classified as paroxysmal: self-terminating episodes of AF for up to 7 days; persistent: AF lasting more than 7 days and usually requiring some kind of antiarrhythmic therapy to restore sinus rhythm; and permanent: persistent AF lasting more than 1 year or failure to restore sinus rhythm despite multiple antiarrhythmic therapies.
Specific treatment parameters that were collected include referral source, type of therapy, specific antiarrhythmic drugs prescribed by the treating physician at the index visit and methods of monitoring AF. Follow-up information collected included absence of AF, use of catheter ablation, last documented rhythm, all-cause mortality, stroke/transient ischemic attack, and AF-related hospitalization.
Last documented rhythm is the rhythm recorded at the last office visit or last electrocardiogram (ECG). Methods of monitoring AF were grouped into 2 categories, ECG and long term monitoring. The latter includes 24-h Holter monitoring, event monitoring, and implantable devices that monitor AF.
Information on mortality was obtained from the social security death index. AF related hospitalizations included admissions for drug loading, cardioversion, or AF with rapid ventricular response rate.
The study was approved by the Northwestern University Institutional Review Board.
Data analysis
Categorical variables are expressed as absolute numbers and percentages; quantitative variables are expressed as mean ± standard deviation (SD). Proportions were compared using 2-proportion Z-test and continuous variables compared using T-test. A p < 0.05 was considered significant.
Results
There were 94 patients managed by cardiologists and 94 patients managed by electrophysiologists with a mean follow-up duration of 14.0 ± ± 11.6 and 12.8 ± 11.1 months, respectively. Table 1 shows the patient characteristics. The patients seen by the general cardiologists were older compared to those seen by the electrophysiologists (70.0 ± 11.8 vs. 65.3 ± 10.3 years, p = 0.002).
There was no significant difference in hypertension, prior stroke, or prior myocardial infarction between the two groups. Diabetes mellitus (21.3% vs. 10.6%, p = 0.046), renal disease (29.0% vs. 9.2%, p = 0.001), coronary artery disease (40.4% vs. 23.4%, p = 0.01) and coronary artery bypass surgery (17.0% vs. 6.4%, p = 0.02) were more common in the patients seen by cardiologists vs. electrophysiologists. More patients seen by cardiologists had been on amiodarone (19% vs. 6%, p = 0.005) prior to the index visit compared to electrophysiologists. Only 3 patients seen by electrophysiologists had had prior catheter ablations.
Referral sources to electrophysiologists were from "Cardiologists" (17%), "Primary care provider" (79.8%), "Self referrals" (2.1%) and "Cardiothoracic surgeon" (1.1%). In comparison, referral sources to cardiologists were 3.2%, 73.4%, 9.6% and 13.8%, respectively.
The type of AF varied between the two groups. While there was no significant difference in the proportion of patients with paroxysmal AF (55.3% vs. 60.6%, p = 0.46), there were more patients with persistent AF seen by electrophysiologists (31.9% vs. 13.8%, p = 0.003) and fewer patients with permanent AF (12.8% vs. 25.5%, p = 0.03). The median CHADS2 score was 2 for patients seen by cardiologists vs. 1 for patients seen by electrophysiologists.
Treatment parameters
Cardiologists employed a rate control strategy more often (80.9% vs. 54.3%, p < 0.001) than electrophysiologists. Consequently, antiarrhythmic drugs were prescribed less often (10.6% vs. 31.9%, p < 0.001). Cardiologists used fewer antiarrhythmic drugs (amiodarone: 80% and sotalol: 20%) vs. the broader array of antiarrhythmic drugs (amiodarone: (Table 2) . Of the 18 and 43 patients treated by cardiologists and electrophysiologists with a rhythm control strategy, the last documented rhythm was sinus in 83.3% and 83.7%, respectively. In these patients, long-term monitoring was used less by cardiologists (55.6% vs. 74.4%, p = 0.15) (Table 3) . However, AF was detected in follow-up, among those treated with a rhythm control strategy, in 27.8% of patients treated by cardiologists and 65.1% of those treated by electrophysiologists (p = 0.008). Catheter ablation was used less (0% vs. 11.6%, p = 0.13) among cardiologists than among electrophysiologists.
Of the patients treated with a rate control strategy, long-term monitoring was used less by cardiologists (n = 76) compared to electrophysiologists (n = 51) (34.2% vs. 64.7%, p = 0.0007), respectively (Table 3) .
At the last follow-up visit, more patients treated by cardiologists were treated with a rate control strategy (91.5% vs. 60.6%, p < 0.001) than at the index visit.
AF-related hospitalization did not differ between patients managed by cardiologists vs. electrophysiologists (38.3% vs. 40.4%, p = 0.88). All cause mortality was 13.8% among patients treated by cardiologists compared to 6.4% among patients treated by electrophysiologists (p = 0.09).
Discussion
This study shows significantly different practice patterns for treatment of AF between general cardiologists and electrophysiologists in a single academic practice. The most notable differences between the two groups are in treatment strategy, array of antiarrhythmic drugs used for treatment, and type of monitoring used. As this is not a randomized study and patient characteristics clearly differed between the two groups, it is not possible to make conclusions regarding outcomes, except to note that major differences were not observed. Importantly, these data represent practice patterns at this institution, and may not be representative of other institutions. As there is no dominant strategy for the treatment of AF, delineating these practice patterns can provide an important window into the [12, 13] recommend an individualized approach to treatment based on variables such as patient's age, degree and frequency of symptoms, activity level and other cardiovascular comorbidities. It suggests that rate control may be appropriate in older patients with minor symptoms, while rhythm control can be used in patients with symptoms despite adequate rate control, and in young patients in whom catheter ablation may be an option. Indeed, in the present study, the patients seen by electrophysiologists were younger, with less cardiovascular comorbidity, perhaps explaining the greater use of rhythm control by electrophysiologists compared to cardiologists. While rhythm control may benefit patients with symptomatic AF, on a population basis, it does not improve survival [14] [15] [16] [17] 21] nor quality of life [14, 16, 18, 21, 23] compared to rate control, highlighting the importance of individualizing therapy as indicated in the guidelines [13] .
Notably, even among patients treated with a rhythm control strategy, the electrophysiologists used a broader array of antiarrhythmic drugs. This may reflect increased familiarity or comfort with antiarrhythmic drugs among electrophysiologists. Additionally, there are barriers to prescription of some antiarrhythmic drugs, such as dofetilide, which requires approval training prior to prescription.
Monitoring for AF during follow-up depends greatly on the goal of therapy [12, 13] . If the goal is to restore sinus rhythm, then more intense monitoring with long-term monitoring is appropriate [24] [25] [26] . On the other hand, if the goal is symptom control, less intensive monitoring may be adequate [24, 27] . Our study showed more intensive monitoring by electrophysiologists compared to cardiologists in patients treated with a rate control strategy. This practice may be useful for assessing the burden of AF in asymptomatic patients [24] , guide ventricular rate control, anticoagulation therapy and to guide further decisions to cross over to a rhythm control strategy [28] . Intensive monitoring will affect the number of patients with documented AF during follow-up [24] [25] [26] [27] [28] . Furthermore, increased use of amiodarone, which is a moderately effective antiarrhythmic drug [29, 30] , by cardiologists may have contributed to the lower proportion of documented AF on follow-up.
Limitations of the study
The major limitation of this study is that it reflects the practice patterns at one institution and cannot necessarily be generalized to other practices. Furthermore, it is a small, non-randomized study with potential referral bias based on different patient characteristics between the two groups.
Conclusions
In summary, physicians who are performing primary evaluations of patients with AF need to formulate a general treatment approach to AF individualized to their patient, understand the practice patterns of the physicians to whom they refer patients, and make informed decisions about which type of specialist may be most appropriate for their patient.
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